Illumina Ventures raises $325m to support genomics start-ups
The fund will be used to support start-ups developing breakthrough life science tools, clinical diagnostics, therapeutics platforms, digital…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Sep 21
The fund will be used to support start-ups developing breakthrough life science tools, clinical diagnostics, therapeutics platforms, digital…
18 Aug 21
The acquisition of SignalPath's CTMS platform will allow Verily to strengthen and expand its existing clinical trial system…
16 Aug 21
The researchers have identified a new approach to treat diseases that are characterised by inflammation and pain, including…
13 Aug 21
With the acquisition, both companies will produce Canada’s first 100% compostable nonwoven fabrics using sustainably sourced biopolymers
28 Jul 21
The new funding would help the company address the demand for its highly differentiated products and procedural solutions…
09 Jul 21
The Celluma RESTORE is non-toxic, non-invasive, and painless. The device is versatile, convenient, and easy-to-use in both a…
29 Jun 21
Johnson & Johnson subsidiary Ethicon believes its Plus Sutures may help take pressure off the NHS as elective…
08 Jun 21
Medical hydrogels could become tough enough for use in artificial joints and ligaments after new findings published by…
11 May 21
Swedish researchers may have shed light on an elusive part of the science behind hearing, and the findings…
26 Apr 21
Royal Rehab is the first certified centre to bring EksoNR to Australia